I believe it will be distribution news. Mu understanding is that the Arysta connection will underpin this and that Bug Oil will indeed be a viable product. I think the main reason the market did not react is that the last RNS was only part of the jigsaw.
Mr Tea, what good news might that be then? I take it you are not referring to the news that bugoil registration in the US is about to be granted? Because if you read the last notification you will see that it has already been granted, subject to any comments from the general public over a 30 day notice period. The reason the share price has not reacted as it well might have done is because the rights owners appear not to want to do anything with it now, after having waited for over 2 years. The price is depressed because there is still a big question mark over the company's finances. In my view, there is a high rate of cash burn and as yet insufficient generated income.
and how I have been wishing I had sold on the Arysta spike last year. However, things are really falling in place nd this will be back on the radar for a lot of investors. Could be some very good news soon. Se riddler's post for basis of the optimism
that Arysta deal on Monday was CLEAERLY with knowledge of this news, as Proactiv Investors shos today
The 30-day public comment period will end on 21 March this year, which means that a final registration decision could be issued as soon as on April 4.
“Today's news from the EPA means we are in the final stages of our US registration effort, and that a US registration is very likely to be received by early April,” said director of product development at Plant Impact Steve Adams.
“We are delighted to see that our many years of effort on the BugOil EPA registration will deliver a registered product into the market.”
The BugOil product, which targets “economically impactful” insect and mite species, was submitted to the EPA for registration in late 2009 and has since been under review.
Earlier this week, Plant Impact revealed changes to its agreement with Arysta LifeScience Corporation over BugOil, which it said would markedly improve its cash outlook
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.